Nanotechnology in Drug Delivery: Market Research Report

September 2018 | 151 pages | ID: N2057EE2B45EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Nanotechnology in Drug Delivery in US$ Million. The Global Market is further analyzed by the following Delivery Technologies: Nanocrystals, and Nanocarriers.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2024. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs.

The report profiles 43 companies including many key and niche players such as -

• AbbVie, Inc.
• Aquanova AG
• BlueWillow Biologics
• Camurus AB
• Celgene, Inc.
• Ceramisphere Health Pty Limited

Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Nanotechnology and Nanomedicine
Nanotechnology in Drug Delivery
Nanotechnology Drug Delivery Systems
Nanocrystals
Nanocarriers

2. OUTLOOK

Nanotechnology, A Critical Part of Healthcare Reform

Table 1. Reliance On Nanotechnology as a Tool to Increase Quality of Affordable Care Increases as Growing Number of Healthcare Businesses Align Their Operational Goals With Value-Based Reimbursement (VBR) % of VBR & Fee-For-Service Structured Healthcare Organizations for the Years 2016, 2018 and 2022 (includes corresponding Graph/Chart)

Nanomedicine, Revolutionizing the Basics of Medicine
A Peek Into the Evolving Role of Nanoparticles in Nanomedicine
Nanocrystals Continue to Gain Momentum as Alternatives to Traditional Nanocarriers
Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes
Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery
List of Marketed Liposome-Based Clinical Products Classified by Therapeutic Areas
Multifunctional Dendrimers Present an Ideal Structure for Targeted Drug Delivery
List of Commercially Available Dendrimeric Products by Application Area
High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems

Table 2. Growing Global Burden of Cancer Throws the Spotlight on Cancer Nanomedicine Valued for its Sensitive Cancer Detection & Targeted Therapy Delivery: Global Cancer New Incidence & Number of Deaths (in 000s) by Type for the Year 2018 (includes corresponding Graph/Chart)

Table 3. Global Cancer New Incidence & Number of Deaths (in 000s) by Geographic Region for the Year 2018 (includes corresponding Graph/Chart)

Nanotechnology-Based Strategies for siRNA Grows in Popularity

Table 4. Growing Interest in Gene Therapy Drives Opportunities for Nanomaterials to Overcome Challenges of Gene Delivery: Global Cell & Gene Therapy Market (in US$ Million) for the Years 2013, 2019 and 2022 (includes corresponding Graph/Chart)

NEM Devices as Drug Delivery Vehicles
Nanotechnology - In Pursuit of Co-Delivery of Drugs
Nanoemulsions Begin to Make a Mark
Growing Need for Alternative Approaches to Conventional Chemotherapy Creates Opportunities for Nanoparticles
Stimuli Responsive Polymeric Micelles Promise Enhanced Therapeutic Effect for Hydrophobic Anticancer Drugs
Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy
Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery
Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest
Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery
SLNs in Pulmonary Delivery of Drugs
Other Nanocarriers in Pulmonary Delivery
Nanotechnology Finds Increasing Role in Fighting Infectious Diseases
List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
Nanotechnology Opening New Avenues in Antiretroviral Therapy
Demonstrated Activity of Select Nanotechnology- Delivered Antiretroviral Therapies
Nanotechnology in Delivery of CNS Therapeutics
Market Challenges
Increasing Environmental and Health Concerns
Limited Success and Scaling Up Issues Pose a Major Hurdle to Further Advancement
Higher Concentration of Research in Academia limits Commercialization
Collaborations Assume Importance
Nanomedicine Regulation
Market Outlook

3. PRODUCT OVERVIEW

Defining Nanotechnology and Nanomedicine
Nanotechnology in Drug Delivery
Applications of Nanoparticles in Drug Delivery
Nanotechnology-Based Drug Delivery Technologies by Segment
Nanocrystals
Nanocarriers
Nanostructures in Drug Delivery
Features of a Rational Nanocarrier
List of Select Nanomaterials Being Studied or Developed for Drug Delivery
Drug Delivery Technologies, Forms and Materials
Overview of Select Major Nanocarriers
Comparison of Key Attributes of Select Major Nanocarriers
Liposomes
List of Select Drugs/Compounds Demonstrated for Efficacious Liposome-based Delivery
Polymeric Nanoparticles
List of Select Drugs Demonstrated for Efficacious Polymeric Nanoparticle-based Delivery
Dendrimers
List of Select Drugs Demonstrated for Efficacious Dendrimer-based Delivery
Solid Lipid Nanoparticles (SLNs)
Nanotubes
List of Select Drugs Demonstrated for Efficacious Nanotube-based Delivery
Polymeric Micelles
Nanocapsules
Fullerenes
Nanostructure Synthesis
Top-Down Approach
Bottom-Up Approach
Requisites for Optimal Nanoparticle Design
Size and Surface Charge of the Nanoparticle
PEGylation and Ligand Functionalization
A Review of Select Nanotechnology-Based Delivery Systems in Anti-Cancer Therapies
Albumin – A Key Delivery Vehicle
Micellar Nanoparticle Formulation of Paclitaxel
Liposomal Formulation of Anti-Cancer Therapies
Dendrimers Finding Extending Use in Nanoparticle-based Anti-Cancer Drug Delivery
Polymeric Micelles in Cancer Drug Delivery
List of Select Nanoparticle Drug Delivery Systems and Uses in Cancer Therapies

4. COMPETITIVE LANDSCAPE

4.1 Focus on Select Players
AbbVie Inc. (USA)
Aquanova AG (Germany)
BlueWillow Biologics (USA)
Camurus AB (Sweden)
Celgene, Inc. (Canada)
Ceramisphere Health Pty Limited (Australia)
Cristal Therapeutics (The Netherlands)
CYTIMMUNE SCIENCES, INC. (Italy)
EnColl Corporation (USA)
EyePoint Pharmaceuticals (USA)
Lena Nanoceutics Ltd. (UK)
NanOlogy LLC (USA)
NanoCarrier Co., Ltd. (Japan)
Nanobiotix (France)
Nanospectra Biosciences, Inc (USA)
Parvus Therapeutics Inc. (USA)
Selecta Biosciences (USA)
Starpharma Holdings Limited (Australia)
Taiwan Liposome Co. (Taiwan)
Tarveda Therapeutics (USA)
4.2 Recent Industry Activity
Alkermes’ NDA for ALNCD to Seek Approval from FDA
NanoBio Changes Name to BlueWillow Biologics
pSivida Acquires Icon Bioscience and Rebrand as EyePoint Pharmaceuticals
Ceramisphere Announces Spin-Off of its Ceramisphere Health
NanOlogy Launches Trials Evaluating its Nanoparticle Suspension
NanoCarrier Collaborates with JCR Pharmaceuticals for Drug Delivery
DFB Pharmaceuticals Collaborates with CritiTech and US Biotest and forms NanOlogy
Flamel Merges with Avadel

5. GLOBAL MARKET PERSPECTIVE

Table 5. World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

Table 6. World 10-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2015, 2018 and 2024 (includes corresponding Graph/Chart)

Table 7. World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanocrystals and Nanocarriers Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

Table 8. World 10-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Dollar Sales for Nanocrystals and Nanocarriers Markets for Years 2015, 2018 and 2024 (includes corresponding Graph/Chart)

6. REGIONAL MARKET PERSPECTIVE

6.1 The United States
A. Market Analysis
Current & Future Analysis
Market Overview
FDA’s Regulatory Approach to Nanotechnology Products
Few Challenges Faced by FDA
B. Market Analytics

Table 9. The US Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

6.2 Canada
Market Analysis

Table 10. Canadian Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

6.3 Japan
A. Market Analysis
Current & Future Analysis
Regulations on Nanomedicine in Japan
B. Market Analytics

Table 11. Japanese Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

6.4 Europe
A. Market Analysis
Current & Future Analysis
Harmonization Of Regulations – A Key Goal for Ema
B. Market Analytics

Table 12. European Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

Table 13. European 10-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2018 and 2024 (includes corresponding Graph/Chart)

  6.4.1 France
A. Market Analysis
Current & Future Analysis
Regulations on Nanomaterials
B. Market Analytics

Table 14. French Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

  6.4.2 Germany
A. Market Analysis
Current & Future Analysis
Germany – A Regional Hub for Nanomedicine Research
B. Market Analytics

Table 15. German Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

  6.4.3 Italy
Market Analysis

Table 16. Italian Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

  6.4.4 The United Kingdom
Market Analysis

Table 17. UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

  6.4.5 Spain
Market Analysis

Table 18. Spanish Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

  6.4.6 Russia
Market Analysis

Table 19. Russian Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

  6.4.7 Rest of Europe
Market Analysis

Table 20. Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

6.5 Asia-Pacific
Market Analysis

Table 21. Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

Table 22. Asia-Pacific 10-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Dollar Sales for China and Rest of Asia-Pacific Markets for Years 2015, 2018 and 2024 (includes corresponding Graph/Chart)

  6.5.1 China
A. Market Analysis
Current & Future Analysis
New Findings Reinforce Role of Silica Nanoparticles in Drug Delivery and Diagnostics
Nanotechnology Patent Profile in China
B. Market Analytics

Table 23. Chinese Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

  6.5.2 Rest of Asia-Pacific
A. Market Analysis
Current & Future Analysis
Indian Nanotechnology Market – An Overview
B. Market Analytics

Table 24. Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

6.6 Latin America
Market Analysis

Table 25. Latin American Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

6.7 Rest of World
Market Analysis

Table 26. Rest of World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2024 (includes corresponding Graph/Chart)

7. COMPANY PROFILES

Total Companies Profiled:
The United States (19)
Canada (1)
Japan (2)
Europe (14)
  France (3)
  Germany (2)
  The United Kingdom (4)
  Rest of Europe (5)
Asia-Pacific (Excluding Japan) (7)